Skip to main content
. 2025 Jun 30;35(4):460–469. doi: 10.25259/IJN_385_2024

Table 7:

Detailed evaluation for secondary causes of hypertension8

Clinical diagnosis Confirmatory evaluation
Glomerulonephritis

Serum C3, C4, ASO

Autoantibodies (ANA/anti dsDNA/ANCA)

Renal biopsy

Reflux nephropathy

Micturating cystourethrogram

Nuclear scan (DMSA/MAG3)

Renovascular disease

Plasma renin/aldosterone levels

Kidney doppler (low sensitivity)

CT/MR renal angiography (>95% sensitive)

Digital subtraction angiography – Gold standard

Pheochromocytoma

Urine and plasma metanephrines

MIBG scan

CT/MRI abdomen

Arteriography and caval catecholamine sampling

Hyperthyroidism or hypothyroidism Thyroid stimulating hormone, free T4 and free T3

Endocrine causes

Cushings syndrome

Primary aldosteronism

Overnight dexamethasone suppression test, 24 hour urinary free cortisol

Plasma aldosterone renin ratio

Coarctation of aorta Echocardiogram
Neuroblastoma Vanillylmandelic acid (VMA), homovanillic acid (HMA)
Monogenic Hypertension

Aldosterone and renin levels

Genetic testing

ASO: Antistreptolysin O, ANA: Antinuclear antibody, dsDNA: Double-stranded deoxyribonucleic acid, ANCA: Anti-neutrophil cytoplasmic antibody, DMSA: Dimercaptosuccinic acid, MAG3: Mercaptuacetyltriglycine, CT: Computed tomography, MR: Magnetic resonance, MIBG: Metaiodobenzylguanidine, MRI: Magnetic resonance imaging